text: Genetic alterations in oncogenic KRAS and tumor suppressors TP53, CDKN2A, SMAD4, ARID1A, and MLL3 are found in pancreatic cancers.(7) Cancer-associated fibroblasts (CAFs), as part of the tumor microenvironment, also play an important role in tumor initiation and progression, as well as drug efficacy.